冠状动脉疾病的多基因风险评分的临床应用贯穿了整个生命过程
Akl C Fahed1, Pradeep Natarajan1
1Cardiovascular Research Center, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Center for Genomic Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
冠状动脉疾病 (CAD) 的多基因风险评分提供了更好的预防和治疗策略. 这些分数可以早期识别有风险的个体,并指导整个生命的精确干预.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 预防性心脏病学 预防性心脏病学
背景情况:
- 冠状动脉疾病 (CAD) 是全球主要的健康负担.
- 目前对CAD的预防策略存在局限性.
研究的目的:
- 审查对CAD的多基因风险评分 (PRS) 的应用.
- 探索PRS如何增强预防和治疗框架.
主要方法:
- 在CAD中审查现有的PRS文献.
- 分析PRS在不同生命阶段和临床情景中的实用性.
主要成果:
- PRS可以在生命早期确定患有CAD高风险的个体.
- 在中年时代,PRS提高了风险预测准确度.
- 在CAD发病后,PRS可以指导治疗决策和临床试验设计.
结论:
- 在个人化CAD预防和治疗方面,PRS具有显著的潜力.
- 对于CAD的PRS的广泛临床实施需要进一步开发和验证.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
相关概念视频
Coronary Artery Disease I: Introduction
Polygenic Traits
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
